A potential treatment for preventing fibrosis following a heart attack and for inhibiting the cell signaling that triggers cancer metastasis; a technology platform to prevent the buildup of biological materials, or foulants, on surfaces such as medical implants; and novel biological and chemical sensors based on carbon nanomaterials, have been selected as recipients of the Chancellor’s Innovation Commercialization Funds.
Read More
